Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Momenta Pharmaceuticals Inc have a median target of 16.00, with a high estimate of 26.00 and a low estimate of 6.00. The median estimate represents a +3.56% increase from the last price of 15.45.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Hold stock in Momenta Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Hold rating.Move your mouse over pastmonths for detail

Earnings and Sales Forecasts

Current Quarter

Earnings per Share-$0.42

Sales$28.3M

Reporting DateNov 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.